Analysis of plasmid-mediated quinolone and oxyimino-cephalosporin resistance mechanisms in Uruguayan Salmonella enterica isolates from 2011–2013

Journal of Global Antimicrobial Resistance

Volumn 6, Issue , 2016, Pages 165-171

  Cordeiro, Nicolás F ^a   Nabón, Adriana ^b   García Fulgueiras, Virginia ^a,b   Álvez, Marcelo ^a   Sirok, Alfredo ^b   Camou, Teresa ^b   Vignoli, Rafael ^a  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b Departamento de Laboratorios   (Uruguay)

Author keywords

PMQR; Salmonella; Lactamase

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 8; BETA LACTAMASE SHV; BETA LACTAMASE SHV 2; BORONIC ACID DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; OXYIMINO CEPHALOSPORIN; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ALLELE; AMINO ACID SEQUENCE; AMPC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CONJUGATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; CLONE; CONTROLLED STUDY; DISK DIFFUSION; GYRA GENE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PARC GENE; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QNRB GENE; QNRB19 GENE; SALMONELLA ENTERICA; URUGUAYAN; CEPHALOSPORIN RESISTANCE; DRUG EFFECT; GENETICS; MICROBIAL SENSITIVITY TEST; SALMONELLOSIS; URUGUAY;

ANTI-BACTERIAL AGENTS; CEPHALOSPORIN RESISTANCE; CIPROFLOXACIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; QUINOLONES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; URUGUAY;

EID: 84978811176     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2016.06.002     Document Type: Article

References (39)

1. [1] Majowicz, S.E., Musto, J., Scallan, E., Angulo, F.J., Kirk, M., O'Brien, S.J., et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50 (2010), 882–889.
2. [2] European Food Safety Authority, Salmonella. 2015, EFSA http://www.efsa.europa.eu/en/topics/topic/salmonella.htm [accessed 15.08.15].
3. [3] United States Department of Agriculture, Economic Research Service. Cost estimates of foodborne illnesses. 2015, USDA http://www.ers.usda.gov/data-products/cost-estimates-of-foodborne-illnesses.aspx#48446 [accessed 15.08.15].
4. [4] Guerrant, R.L., Van Gilder, T., Steiner, T.S., Thielman, N.M., Slutsker, L., Tauxe, R.V., et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32 (2001), 331–351.
5. [5] Solnik-Isaac, H., Weinberger, M., Tabak, M., Ben-David, A., Shachar, D., Yaron, S., Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J Clin Microbiol 45 (2007), 2575–2579.
6. [6] Jacoby, G.A., Strahilevitz, J., Hooper, D.C., Plasmid-mediated quinolone resistance. Microbiol Spectr, 2, 2014, 10.1128/microbiolspec.PLAS-0006-2013.
7. [7] Burke, L., Hopkins, K.L., Meunier, D., de Pinna, E., Fitzgerald-Hughes, D., Humphreys, H., et al. Resistance to third-generation cephalosporins in human non-typhoidal Salmonella enterica isolates from England and Wales, 2010–12. J Antimicrob Chemother 69 (2014), 977–981.
8. [8] Cordeiro, N.F., Chabalgoity, J.A., Yim, L., Vignoli, R., Synthesis of metallo-β-lactamase VIM-2 is associated with a fitness reduction in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 58 (2014), 6528–6535.
9. [9] Garcia-Fulgueiras, V., Bado, I., Mota, M.I., Robino, L., Cordeiro, N.F., Varela, A., et al. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother 66 (2011), 1725–1729.
10. [10] Cordeiro, N.F., Robino, L., Medina, J., Seija, V., Bado, I., García, V., et al. Ciprofloxacin-resistant enterobacteria harboring the aac(6′)-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay. Antimicrob Agents Chemother 52 (2008), 806–807.
11. [11] World Health Organization, Antimicrobial resistance: global report on surveillance. 2014, WHO http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf [accessed 20.08.15].
12. [12] Clinical Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. Document M100-S25. 2015, CLSI, Wayne, PA.
13. [13] Cejas, D., Vignoli, R., Quinteros, M., Marino, R., Callejo, R., Betancor, L., et al. First detection of CMY-2 plasmid mediated β-lactamase in Salmonella Heidelberg in South America. Rev Argent Microbiol 46 (2014), 30–33.
14. [14] Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
15. [15] Swaminathan, B., Barrett, T.J., Hunter, S.B., Tauxe, R.V., PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis 7 (2001), 382–389.
16. [16] Vignoli, R., García-Fulgueiras, V., Cordeiro, N.F., Bado, I., Seija, V., Aguerrebere, P., et al. Extended-spectrum β-lactamases, transferable quinolone-resistance and virulotyping in extra-intestinal E. coli in Uruguay. J Infect Dev Ctries 10 (2016), 43–52.
17. [17] Bado, I., Cordeiro, N.F., Robino, L., García-Fulgueiras, V., Seija, V., Bazet, C., et al. Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of intensive care unit inpatients. Int J Antimicrob Agents 36 (2010), 453–458.
18. [18] Vignoli, R., Cordeiro, N.F., García, V., Mota, M.I., Betancor, L., Power, P., et al. New TEM-derived extended-spectrum β-lactamase and its genomic context in plasmids from Salmonella enterica serovar Derby isolates from Uruguay. Antimicrob Agents Chemother 50 (2006), 781–784.
19. [19] Pérez-Pérez, F.J., Hanson, N.D., Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40 (2002), 2153–2162.
20. [20] Kim, H.B., Park, C.H., Kim, C.J., Kim, E.C., Jacoby, G.A., Hooper, D.C., Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53 (2009), 639–645.
21. [21] Chen, X., Zhang, W., Pan, W., Yin, J., Pan, Z., Gao, S., et al. Prevalence of qnr, aac(6′)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment. Antimicrob Agents Chemother 56 (2012), 3423–3427.
22. [22] Sambrook, J., Fritsch, E.F., Maniatis, T., Molecular cloning. A laboratory manual. 2nd ed., 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. [23] Barton, B.M., Harding, G.P., Zuccarelli, A.J., A general method for detecting and sizing large plasmids. Anal Biochem 226 (1995), 235–240.
24. [24] Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L., Threlfall, E.J., Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63 (2005), 219–228.
25. [25] Mnif, B., Vimont, S., Boyd, A., Bourit, E., Picard, B., Branger, C., et al. Molecular characterization of addiction systems of plasmids encoding extended-spectrum β-lactamases in Escherichia coli. J Antimicrob Chemother 65 (2010), 1599–1603.
26. [26] Pallecchi, L., Riccobono, E., Sennati, S., Mantella, A., Bartalesi, F., Trigoso, C., et al. Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal enterobacteria. Antimicrob Agents Chemother 54 (2010), 678–682.
27. [27] Macedo-Viñas, M., Cordeiro, N.F., Bado, I., Herrera-Leon, S., Vola, M., Robino, L., et al. Surveillance of antibiotic resistance evolution and detection of class 1 and 2 integrons in human isolates of multi-resistant Salmonella Typhimurium obtained in Uruguay between 1976 and 2000. Int J Infect Dis 13 (2009), 342–348.
28. [28] Veldman, K., Cavaco, L.M., Mevius, D., Battisti, A., Franco, A., Botteldoorn, N., et al. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J Antimicrob Chemother 66 (2011), 1278–1286.
29. [29] Karczmarczyk, M., Martins, M., McCusker, M., Mattar, S., Amaral, L., Leonard, N., et al. Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars. FEMS Microbiol Lett 313 (2010), 10–19.
30. [30] Tran, T., Andres, P., Petroni, A., Soler-Bistue, A., Albornoz, E., Zorreguieta, A., et al. Small plasmids harboring qnrB19: a model for plasmid evolution mediated by site-specific recombination at oriT and Xer sites. Antimicrob Agents Chemother 56 (2012), 1821–1827.
31. [31] González, F., Araque, M., Association of transferable quinolone resistance determinant qnrB19 with extended-spectrum β-lactamases in Salmonella Give and Salmonella Heidelberg in Venezuela. Int J Microbiol, 2013, 628185.
32. [32] Wong, M.H., Yan, M., Chan, E.W., Biao, K., Chen, S., Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother 58 (2014), 3752–3756.
33. [33] Eaves, D.J., Randall, L., Gray, D.T., Buckley, A., Woodward, M.J., White, A.P., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother 48 (2004), 4012–4015.
34. CMY-2 gene in Salmonella enterica serovar Typhimurium isolates obtained from cases of paediatric diarrhoea illness detected in South America. J Glob Antimicrob Resist 1 (2013), 143–148.
35. [35] Bado, I., Gutiérrez, C., García-Fulgueiras, V., Cordeiro, N.F., Araújo Pírez, L., Seija, V., et al. CTX-M-15 in combination with aac(6′)-Ib-cr is the most prevalent mechanism of resistance both in Escherichia coli and Klebsiella pneumoniae, including K. pneumoniae ST258, in an ICU in Uruguay. J Glob Antimicrob Resist 6 (2016), 5–9.
36. CTX-M-14 in South America. Antimicrob Agents Chemother 56 (2012), 2132–2134.
37. [37] Peirano, G., Agerso, Y., Aarestrup, F.M., dos Reis, E.M., dos Prazeres Rodrigues, D., Occurrence of integrons and antimicrobial resistance genes among Salmonella enterica from Brazil. J Antimicrob Chemother 58 (2006), 305–309.
38. [38] Eller, C., Leistner, R., Guerra, B., Fischer, J., Wendt, C., Rabsch, W., et al. Emergence of extended-spectrum β-lactamase (ESBL) CTX-M-8 in Germany. J Antimicrob Chemother 69 (2014), 562–564.
39. [39] Dhanji, H., Murphy, N.M., Doumith, M., Durmus, S., Surman Lee, S., Hope, R., et al. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J Antimicrob Chemother 65 (2010), 2534–2537.